Characteristic basal ganglia injury in fentanyl- and cocaine-related hypoxic brain injury: a case report.
Yellin Emma E, Arnsten Amy A, Vives-Rodriguez Ana A, Fesharaki-Zadeh Arman A
We present the case of a 33-year-old woman who developed bilateral basal ganglia injury following a hypoxic brain injury in the setting of fentanyl and cocaine use. Notably, she never required intubation and received only minimal supplemental oxygen, yet MRI demonstrated bilateral basal ganglia diffusion restriction on diffusion-weighted imaging (DWI) with corresponding T2/FLAIR hyperintensities, findings most associated with significant ischemic injury. Rather than the movement disorders typically seen with basal ganglia lesions, her predominant presentation was neuropsychiatric, characterized by apathy, impulsivity, and risk-taking behavior. Drawing on the mechanistic overlap with traumatic brain injury affecting Prefrontal cortical (PFC) and subcortical networks, she was treated with a novel combination of guanfacine, bupropion, and N-acetylcysteine (NAC), targeting executive dysfunction, apathy, and neuroinflammatory pathways, respectively. This case highlights a rare neuropsychiatric presentation of drug-related hypoxic basal ganglia injury and provides a framework for understanding and treating the behavioral sequelae of such injury. It also adds to a small but growing body of literature linking opioid overdose to characteristic basal ganglia diffusion restriction, even in the absence of overt hypoxia.